Skip to content

Ten Versus Fifteen Centimeter Pouch in IPAA Surgery

Ileal Reservoir Length and Functional Outcome in Ileal Pouch-anal Anastomosis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06538402
Acronym
TESTIMONY
Enrollment
120
Registered
2024-08-05
Start date
2025-07-03
Completion date
2038-07-03
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Familial Adenomatous Polyposis, Ulcerative Colitis

Keywords

ileal pouch-anal anastomosis, ulcerative colitis, familial adenomatous polyposis, randomized controlled trial, pouch function, quality of life, complications

Brief summary

The aim of this randomized controlled trial is to compare outcome after construction of an ileal (J-shaped) reservoir of 10 versus 15 centimeters in primary ileal pouch-anal anastomosis surgery.

Detailed description

The primary aim of this randomized controlled trial is to compare functional outcome in terms of bowel function correlated with quality of life for patients who undergo primary ileal pouch-anal anastomosis surgery with an ileal (J-shaped) reservoir length of either 10 cm or 15 cm. Secondary aims include health-related quality of life measures and postoperative complications.

Interventions

PROCEDURE10 cm pouch

A 10 cm pouch will be constructed

PROCEDURE15 cm pouch

A 15 cm pouch will be constructed

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Undergoing ileal pouch-anal anastomosis (IPAA) for ulcerative colitis or familial adenomatous polyposis (FAP) (implying a normal sphincter function as judged by history and clinical examination) * Signed informed consent * Able to perform both a small (10 cm) and medium-size (15 cm) pouch with adequate reach and no tension as determined subjectively by the surgeon intraoperatively

Design outcomes

Primary

MeasureTime frameDescription
Pouch dysfunction score1, 3, 5 and 10 years after surgeryRanges from 0 to 7.5, where a low score indicates good bowel function will little to no impact on quality of life

Secondary

MeasureTime frameDescription
Short Inflammatory Bowel Disease Questionnaire1, 3, 5 and 10 years after surgeryConsists of 10 questions with a total score range from 10 (poor health-related quality of life) to 70 (good health-related quality of life)
Short-form (SF)-361, 3, 5 and 10 years after surgeryConsists of questions relating to 8 domains of life with a total score ranging from 0-100, with lower numbers indicating worse health status
Postoperative complications using the Comprehensive Complication Index (CCI)90 days after surgeryThe CCI is a continuous scale, where each postoperative complication as defined by Clavien-Dindo is assigned a weigth based on its severity. A total summarized score taking all complications into account is thus generated.
Pouch failure1, 3, 5 and 10 years after surgeryHazard ratio of pouch failure defined as an intended permanent ileostomy with or without pouch excision

Countries

Denmark

Contacts

Primary ContactAnders Mark-Christensen, MD, PhD
anders.mark.christensen2@rsyd.dk+45 51236691

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026